Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
38
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Brunn Carsten | President and CEO | 64 | $0 | $384.7K | 2023-09-25 |
| TRABER PETER G | Chief Medical Officer | 25 | $358.6K | $52.0K | 2023-09-25 |
| Kishimoto Takashi Kei | Chief Scientific Officer | 35 | $0 | $227.3K | 2023-05-31 |
| Johnston Lloyd P. | Chief Operations Officer | 46 | $0 | $1.16M | 2023-01-05 |
| Sallin Aymeric | Director | 7 | $0 | $0 | 2023-01-02 |
| DeSilva Nishan M | Director | 4 | $20.7K | $0 | 2023-01-02 |
| Myers Scott Dunseth | Director | 8 | $0 | $0 | 2023-01-02 |
| BARABE TIMOTHY C | Director | 25 | $273.5K | $0 | 2023-01-02 |
| ZENNER PATRICK J | Director | 8 | $0 | $0 | 2023-01-02 |
| COX CARRIE SMITH | Director | 9 | $200.2K | $0 | 2023-01-02 |
| ANDO GORAN | Director | 4 | $0 | $0 | 2023-01-02 |
| SPRINGER TIMOTHY A | Director, 10% Owner | 50 | $61.53M | $0 | 2023-01-02 |
| Davis Blaine | Chief Financial Officer | 1 | $0 | $0 | 2022-11-28 |
| Tan Kevin | Chief Financial Officer | 4 | $15.1K | $0 | 2022-01-03 |
| Dahms Bradford D. | Chief Financial Officer | 5 | $0 | $0 | 2021-01-04 |
| Schecter Alison D. | Chief Medical Officer | 2 | $0 | $0 | 2020-01-02 |
| Smolinski Stephen | Chief Commercial Officer | 6 | $0 | $0 | 2020-01-02 |
| Kogan Elona Esq. | General Counsel | 4 | $0 | $0 | 2020-01-02 |
| Farokhzad Omid | Director | 12 | $125.0K | $0 | 2019-06-14 |
| Nashat Amir | Director, 10% Owner | 55 | $3.85M | $5.77M | 2019-06-14 |
| Abraham David | GC, CCO & Corporate Secretary | 7 | $50.0K | $267.2K | 2018-06-15 |
| Leaman John Harold | CFO, Treas. & Hd Corp Strategy | 2 | $0 | $0 | 2018-06-15 |
| HUTT PETER BARTON | Director | 2 | $0 | $0 | 2018-06-15 |
| Sands Earl | Chief Medical Officer | 3 | $77.0K | $0 | 2017-11-17 |
| CAUTREELS WERNER | President and CEO | 3 | $186.2K | $0 | 2017-11-13 |
| Siewers David | Chief Financial Officer | 18 | $0 | $807.6K | 2017-09-20 |
| Keller Peter | Chief Business Officer | 6 | $0 | $176.4K | 2017-07-07 |
| KANIA EDWIN M JR | Director | 11 | $0 | $3.74M | 2017-05-16 |
| VTB Capital I2BF Netherlands, B.V. | 10% Owner | 4 | $0 | $0 | 2016-06-27 |
| TAS Partners, LLC | Director | 11 | $9.94M | $0 | 2016-06-27 |
| Osage Partners, LLC | 10% Owner | 3 | $4.90M | $0 | 2016-06-27 |
| Nanodimension Limited Partnership | 10% Owner | 6 | $5.39M | $0 | 2016-06-27 |
| RUSNANO | 10% Owner | 7 | $1.50M | $0 | 2016-06-27 |
| Flagship Ventures 2007 General Partner LLC | 10% Owner | 10 | $0 | $0 | 2016-06-27 |
| Polaris Venture Partners Entrepreneurs' Fund V, L.P. | 10% Owner | 28 | $2.10M | $0 | 2016-06-27 |
| GORDON CARL L | Director, 10% Owner | 10 | $7.70M | $0 | 2016-06-27 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 10 | $7.70M | $0 | 2016-06-27 |
| ISALY SAMUEL D | Director, 10% Owner | 10 | $7.70M | $0 | 2016-06-27 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| TRABER PETER G | Chief Medical Officer | S Sale | 2023-09-25 | 2023-09-26 | 705 | $1.06 | $747 | 451,826 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2023-09-25 | 2023-09-26 | 2,932 | $1.06 | $3.1K | 783,081 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | G Gift | 2023-05-31 | 2023-06-01 | 26,500 | — | $0 | 251,816 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | G Gift | 2023-05-31 | 2023-06-01 | 26,500 | — | $0 | 225,316 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | G Gift | 2023-05-30 | 2023-06-01 | 43,000 | — | $0 | 278,316 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | G Gift | 2023-05-30 | 2023-06-01 | 43,000 | — | $0 | 321,316 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | S Sale | 2023-01-05 | 2023-01-06 | 20 | $1.11 | $22 | 446,121 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | S Sale | 2023-01-05 | 2023-01-06 | 3,445 | $1.13 | $3.9K | 446,141 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | S Sale | 2023-01-05 | 2023-01-06 | 20 | $1.11 | $22 | 364,316 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | S Sale | 2023-01-05 | 2023-01-06 | 3,372 | $1.13 | $3.8K | 364,336 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | S Sale | 2023-01-05 | 2023-01-06 | 3,372 | $1.13 | $3.8K | 265,535 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | S Sale | 2023-01-05 | 2023-01-06 | 20 | $1.11 | $22 | 265,515 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2023-01-05 | 2023-01-06 | 77 | $1.12 | $86 | 786,013 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2023-01-05 | 2023-01-06 | 13,396 | $1.13 | $15.1K | 786,090 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | S Sale | 2023-01-04 | 2023-01-06 | 8,164 | $1.13 | $9.2K | 449,601 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | S Sale | 2023-01-04 | 2023-01-06 | 15 | $1.14 | $17 | 449,586 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | S Sale | 2023-01-04 | 2023-01-06 | 6,381 | $1.13 | $7.2K | 367,719 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | S Sale | 2023-01-04 | 2023-01-06 | 11 | $1.15 | $13 | 367,708 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | S Sale | 2023-01-04 | 2023-01-06 | 11 | $1.14 | $13 | 268,907 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | S Sale | 2023-01-04 | 2023-01-06 | 6,381 | $1.13 | $7.2K | 268,918 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2023-01-04 | 2023-01-06 | 27,549 | $1.13 | $31.1K | 799,534 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2023-01-04 | 2023-01-06 | 48 | $1.15 | $55 | 799,486 | SEC↗ |
| ZENNER PATRICK J | Director | A Award deriv | 2023-01-02 | 2023-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award deriv | 2023-01-02 | 2023-01-04 | 900,000 | — | $0 | 900,000 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award deriv | 2023-01-02 | 2023-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Sallin Aymeric | Director | A Award deriv | 2023-01-02 | 2023-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award deriv | 2023-01-02 | 2023-01-04 | 475,000 | — | $0 | 475,000 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | A Award deriv | 2023-01-02 | 2023-01-04 | 475,000 | — | $0 | 475,000 | SEC↗ |
| DeSilva Nishan M | Director | A Award deriv | 2023-01-02 | 2023-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| COX CARRIE SMITH | Director | A Award deriv | 2023-01-02 | 2023-01-04 | 107,500 | — | $0 | 107,500 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2023-01-02 | 2023-01-04 | 1,275,000 | — | $0 | 1,275,000 | SEC↗ |
| BARABE TIMOTHY C | Director | A Award deriv | 2023-01-02 | 2023-01-04 | 87,500 | — | $0 | 87,500 | SEC↗ |
| ANDO GORAN | Director | A Award deriv | 2023-01-02 | 2023-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Myers Scott Dunseth | Director | A Award deriv | 2023-01-02 | 2023-01-04 | 87,500 | — | $0 | 87,500 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award | 2023-01-02 | 2023-01-04 | 200,000 | — | $0 | 457,765 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award | 2023-01-02 | 2023-01-04 | 100,000 | — | $0 | 374,100 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | A Award | 2023-01-02 | 2023-01-04 | 100,000 | — | $0 | 275,299 | SEC↗ |
| Brunn Carsten | President and CEO | A Award | 2023-01-02 | 2023-01-04 | 282,800 | — | $0 | 827,083 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2022-12-05 | 2022-12-07 | 4,522 | $1.33 | $6.0K | 544,283 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2022-12-01 | 2022-12-05 | 10,938 | — | $0 | 0 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2022-12-01 | 2022-12-05 | 10,938 | — | $0 | 548,805 | SEC↗ |
| Davis Blaine | Chief Financial Officer | A Award deriv | 2022-11-28 | 2022-11-30 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2022-09-28 | 2022-09-30 | 2,692 | $1.66 | $4.5K | 537,867 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2022-09-02 | 2022-09-06 | 4,768 | $1.85 | $8.8K | 540,559 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2022-09-01 | 2022-09-06 | 10,937 | — | $0 | 10,938 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2022-09-01 | 2022-09-06 | 10,937 | — | $0 | 545,327 | SEC↗ |
| COX CARRIE SMITH | Director | P Buy | 2022-06-13 | 2022-06-15 | 130,000 | $1.15 | $149.5K | 212,881 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2022-06-01 | 2022-06-03 | 10,938 | — | $0 | 21,875 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2022-06-01 | 2022-06-03 | 10,938 | — | $0 | 534,390 | SEC↗ |
| BARABE TIMOTHY C | Director | P Buy | 2022-05-09 | 2022-05-11 | 50,000 | $0.77 | $38.5K | 250,013 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award deriv | 2022-04-11 | 2022-04-13 | 5,011,200 | — | $0 | 5,011,200 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2022-04-11 | 2022-04-13 | 6,681,600 | — | $0 | 29,868,490 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2022-03-02 | 2022-03-03 | 5,443 | $1.81 | $9.9K | 523,452 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2022-03-01 | 2022-03-03 | 10,937 | — | $0 | 32,813 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2022-03-01 | 2022-03-03 | 10,937 | — | $0 | 528,895 | SEC↗ |
| BARABE TIMOTHY C | Director | M Exercise deriv | 2022-01-14 | 2022-01-18 | 10,000 | $2.10 | $21.0K | 0 | SEC↗ |
| BARABE TIMOTHY C | Director | M Exercise | 2022-01-14 | 2022-01-18 | 10,000 | $2.10 | $21.0K | 200,013 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2022-01-05 | 2022-01-07 | 13,597 | $3.09 | $42.0K | 517,958 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | S Sale | 2022-01-05 | 2022-01-07 | 3,416 | $3.09 | $10.6K | 175,299 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | S Sale | 2022-01-05 | 2022-01-07 | 3,416 | $3.09 | $10.6K | 268,353 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | S Sale | 2022-01-05 | 2022-01-07 | 3,226 | $3.09 | $10.0K | 251,355 | SEC↗ |
| ANDO GORAN | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BARABE TIMOTHY C | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2022-01-03 | 2022-01-05 | 1,056,100 | — | $0 | 1,056,100 | SEC↗ |
| COX CARRIE SMITH | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DeSilva Nishan M | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 340,000 | — | $0 | 340,000 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 340,000 | — | $0 | 340,000 | SEC↗ |
| Myers Scott Dunseth | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Sallin Aymeric | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Tan Kevin | Chief Financial Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 340,000 | — | $0 | 340,000 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 415,900 | — | $0 | 415,900 | SEC↗ |
| ZENNER PATRICK J | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Brunn Carsten | President and CEO | A Award | 2022-01-03 | 2022-01-05 | 226,300 | — | $0 | 531,555 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | A Award | 2022-01-03 | 2022-01-05 | 72,000 | — | $0 | 178,715 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award | 2022-01-03 | 2022-01-05 | 72,000 | — | $0 | 271,769 | SEC↗ |
| Tan Kevin | Chief Financial Officer | A Award | 2022-01-03 | 2022-01-05 | 72,000 | — | $0 | 77,000 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award | 2022-01-03 | 2022-01-05 | 90,200 | — | $0 | 254,581 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2021-12-15 | 2021-12-17 | 211,190 | $2.99 | $631.5K | 23,186,890 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2021-12-13 | 2021-12-13 | 14,592 | $2.98 | $43.5K | 22,975,700 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2021-12-10 | 2021-12-13 | 58,681 | $2.99 | $175.5K | 22,961,108 | SEC↗ |
| President and CEO | S Sale | 2021-12-10 | 2021-12-14 | 17,196 | $2.99 | $51.4K | 305,255 | SEC↗ | |
| Johnston Lloyd P. | Chief Operations Officer | S Sale | 2021-12-10 | 2021-12-14 | 4,370 | $2.99 | $13.1K | 106,715 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | S Sale | 2021-12-10 | 2021-12-14 | 4,370 | $2.99 | $13.1K | 199,769 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | S Sale | 2021-12-10 | 2021-12-14 | 4,083 | $2.99 | $12.2K | 164,381 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2021-12-09 | 2021-12-13 | 3,748,000 | $3.06 | $11.47M | 22,902,427 | SEC↗ |
| Brunn Carsten | President and CEO | A Award | 2021-12-08 | 2021-12-10 | 37,500 | — | $0 | 322,451 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | A Award | 2021-12-08 | 2021-12-10 | 13,750 | — | $0 | 111,085 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award | 2021-12-08 | 2021-12-10 | 13,750 | — | $0 | 204,139 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award | 2021-12-08 | 2021-12-10 | 13,750 | — | $0 | 168,464 | SEC↗ |
| COX CARRIE SMITH | Director | P Buy | 2021-12-03 | 2021-12-06 | 17,200 | $2.95 | $50.7K | 82,881 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2021-12-02 | 2021-12-03 | 4,746 | $2.96 | $14.0K | 284,951 | SEC↗ |
| DeSilva Nishan M | Director | P Buy | 2021-12-02 | 2021-12-06 | 7,000 | $2.96 | $20.7K | 7,000 | SEC↗ |
| Tan Kevin | Chief Financial Officer | P Buy | 2021-12-02 | 2021-12-06 | 5,000 | $3.03 | $15.1K | 5,000 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2021-12-01 | 2021-12-03 | 10,938 | — | $0 | 43,750 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2021-12-01 | 2021-12-03 | 10,938 | — | $0 | 289,697 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2021-10-13 | 2021-10-15 | 15,313 | $4.39 | $67.2K | 278,759 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | S Sale | 2021-10-13 | 2021-10-15 | 3,892 | $4.39 | $17.1K | 97,335 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | S Sale | 2021-10-13 | 2021-10-15 | 3,892 | $4.39 | $17.1K | 190,389 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | S Sale | 2021-10-13 | 2021-10-15 | 3,636 | $4.39 | $16.0K | 154,714 | SEC↗ |
| Brunn Carsten | President and CEO | A Award | 2021-10-01 | 2021-10-05 | 37,500 | — | $0 | 294,072 | SEC↗ |
| Johnston Lloyd P. | Chief Operations Officer | A Award | 2021-10-01 | 2021-10-05 | 13,750 | — | $0 | 101,227 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award | 2021-10-01 | 2021-10-05 | 13,750 | — | $0 | 194,281 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award | 2021-10-01 | 2021-10-05 | 13,750 | — | $0 | 158,350 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2021-09-24 | 2021-09-28 | 163,000 | — | $0 | 163,000 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award deriv | 2021-09-24 | 2021-09-28 | 54,400 | — | $0 | 54,400 | SEC↗ |
| Brunn Carsten | President and CEO | A Award | 2021-09-24 | 2021-09-28 | 27,200 | — | $0 | 256,572 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award | 2021-09-24 | 2021-09-28 | 9,100 | — | $0 | 144,600 | SEC↗ |
| Tan Kevin | Chief Financial Officer | A Award deriv | 2021-09-20 | 2021-09-22 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2021-09-02 | 2021-09-03 | 4,523 | $4.51 | $20.4K | 229,372 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2021-09-01 | 2021-09-03 | 10,937 | — | $0 | 54,688 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2021-09-01 | 2021-09-03 | 10,937 | — | $0 | 233,895 | SEC↗ |
| BARABE TIMOTHY C | Director | P Buy | 2021-08-18 | 2021-08-20 | 9,000 | $4.00 | $36.0K | 190,013 | SEC↗ |
| DeSilva Nishan M | Director | A Award deriv | 2021-06-23 | 2021-07-09 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2021-06-02 | 2021-06-03 | 4,806 | $4.38 | $21.1K | 222,958 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2021-06-01 | 2021-06-03 | 10,938 | — | $0 | 65,625 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2021-06-01 | 2021-06-03 | 10,938 | — | $0 | 227,764 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2021-05-26 | 2021-05-26 | 926,170 | $4.00 | $3.70M | 19,154,427 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | P Buy | 2021-05-26 | 2021-05-27 | 20,000 | $3.99 | $79.8K | 135,500 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | P Buy | 2021-05-25 | 2021-05-26 | 5,000 | $3.48 | $17.4K | 115,500 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2021-05-25 | 2021-05-26 | 383,830 | $3.55 | $1.36M | 18,228,257 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | P Buy | 2021-05-24 | 2021-05-26 | 12,500 | $3.32 | $41.5K | 110,500 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2021-05-24 | 2021-05-26 | 590,000 | $3.38 | $1.99M | 17,844,427 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2021-05-21 | 2021-05-25 | 2,773,479 | $3.19 | $8.85M | 17,254,427 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | M Exercise deriv | 2021-05-07 | 2021-05-11 | 13,629 | — | $0 | 0 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | M Exercise | 2021-05-07 | 2021-05-11 | 13,629 | $2.77 | $37.8K | 177,778 | SEC↗ |
| BARABE TIMOTHY C | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| COX CARRIE SMITH | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Myers Scott Dunseth | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Sallin Aymeric | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award deriv | 2021-03-30 | 2021-04-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ZENNER PATRICK J | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ANDO GORAN | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BARABE TIMOTHY C | Director | P Buy | 2021-03-26 | 2021-03-30 | 10,000 | $4.10 | $41.0K | 181,013 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | P Buy | 2021-03-18 | 2021-03-19 | 10,000 | $4.50 | $45.0K | 98,000 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | S Sale | 2021-03-17 | 2021-03-19 | 15,128 | $4.45 | $67.3K | 87,477 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | P Buy | 2021-03-17 | 2021-03-19 | 10,000 | $4.53 | $45.3K | 88,000 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2021-03-02 | 2021-03-03 | 5,461 | $4.26 | $23.3K | 216,826 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2021-03-01 | 2021-03-03 | 10,937 | — | $0 | 76,563 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2021-03-01 | 2021-03-03 | 10,937 | — | $0 | 222,287 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | M Exercise deriv | 2021-02-11 | 2021-02-16 | 44,871 | — | $0 | 0 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | M Exercise | 2021-02-11 | 2021-02-16 | 44,871 | $0.63 | $28.3K | 102,605 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2021-01-04 | 2021-01-06 | 670,000 | — | $0 | 670,000 | SEC↗ |
| Dahms Bradford D. | Chief Financial Officer | A Award deriv | 2021-01-04 | 2021-01-06 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | A Award deriv | 2021-01-04 | 2021-01-06 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award deriv | 2021-01-04 | 2021-01-06 | 230,000 | — | $0 | 230,000 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award deriv | 2021-01-04 | 2021-01-06 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Brunn Carsten | President and CEO | A Award | 2021-01-04 | 2021-01-06 | 110,000 | — | $0 | 211,350 | SEC↗ |
| Dahms Bradford D. | Chief Financial Officer | A Award | 2021-01-04 | 2021-01-06 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | A Award | 2021-01-04 | 2021-01-06 | 38,000 | — | $0 | 57,734 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award | 2021-01-04 | 2021-01-06 | 38,000 | — | $0 | 164,149 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award | 2021-01-04 | 2021-01-06 | 38,000 | — | $0 | 78,000 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | P Buy | 2020-12-14 | 2020-12-16 | 40,000 | $3.24 | $129.6K | 40,000 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2020-12-02 | 2020-12-03 | 3,323 | $3.35 | $11.1K | 101,350 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2020-12-01 | 2020-12-03 | 10,938 | — | $0 | 87,500 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2020-12-01 | 2020-12-03 | 10,938 | — | $0 | 104,673 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | M Exercise deriv | 2020-10-23 | 2020-10-27 | 30,000 | — | $0 | 13,629 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-23 | 2020-10-23 | 994,488 | $2.71 | $2.70M | 14,480,948 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | M Exercise | 2020-10-23 | 2020-10-27 | 30,000 | $2.77 | $83.1K | 126,149 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-22 | 2020-10-23 | 1,770,204 | $2.63 | $4.66M | 13,486,460 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-21 | 2020-10-23 | 880,000 | $2.50 | $2.20M | 11,716,256 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-20 | 2020-10-20 | 910,000 | $2.21 | $2.01M | 10,836,256 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-19 | 2020-10-20 | 759,500 | $2.36 | $1.79M | 9,926,256 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-16 | 2020-10-20 | 218,196 | $2.42 | $528.0K | 9,166,756 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-09 | 2020-10-14 | 276,703 | $2.00 | $553.4K | 8,948,560 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-08 | 2020-10-08 | 530,441 | $1.89 | $1.00M | 8,671,857 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-07 | 2020-10-08 | 654,953 | $1.65 | $1.08M | 8,141,416 | SEC↗ |
| BARABE TIMOTHY C | Director | P Buy | 2020-10-06 | 2020-10-08 | 50,000 | $1.68 | $84.0K | 171,013 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 2,000,000 | $1.68 | $3.36M | 7,486,463 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2020-09-02 | 2020-09-03 | 3,364 | $2.39 | $8.0K | 93,735 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2020-09-01 | 2020-09-03 | 10,937 | — | $0 | 98,438 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2020-09-01 | 2020-09-03 | 10,937 | — | $0 | 97,099 | SEC↗ |
| TRABER PETER G | Chief Medical Officer | A Award deriv | 2020-08-01 | 2020-08-04 | 650,000 | — | $0 | 650,000 | SEC↗ |
| Brunn Carsten | President & CEO | A Award deriv | 2020-07-01 | 2020-07-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Johnston Lloyd P. | COO & SVP, R&D | A Award deriv | 2020-07-01 | 2020-07-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Dahms Bradford D. | Chief Financial Officer | A Award deriv | 2020-07-01 | 2020-07-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BARABE TIMOTHY C | Director | M Exercise deriv | 2020-06-24 | 2020-06-26 | 32,840 | $0.13 | $4.3K | 0 | SEC↗ |
| BARABE TIMOTHY C | Director | M Exercise | 2020-06-24 | 2020-06-26 | 32,840 | $1.46 | $47.9K | 121,013 | SEC↗ |
| COX CARRIE SMITH | Director | A Award deriv | 2020-06-19 | 2020-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Myers Scott Dunseth | Director | A Award deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Sallin Aymeric | Director | A Award deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZENNER PATRICK J | Director | A Award deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BARABE TIMOTHY C | Director | A Award deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2020-06-02 | 2020-06-03 | 3,253 | $3.86 | $12.6K | 86,162 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2020-06-01 | 2020-06-03 | 10,938 | — | $0 | 109,375 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2020-06-01 | 2020-06-03 | 10,938 | — | $0 | 89,415 | SEC↗ |
| ANDO GORAN | Director | A Award deriv | 2020-04-24 | 2020-04-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BARABE TIMOTHY C | Director | P Buy | 2020-03-17 | 2020-03-19 | 5,000 | $2.00 | $10.0K | 88,173 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2020-03-03 | 2020-03-03 | 3,374 | $3.86 | $13.0K | 78,477 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2020-03-01 | 2020-03-03 | 10,937 | — | $0 | 120,313 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2020-03-01 | 2020-03-03 | 10,937 | — | $0 | 81,851 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | M Exercise deriv | 2020-01-16 | 2020-01-21 | 5,128 | — | $0 | 0 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | M Exercise | 2020-01-16 | 2020-01-21 | 5,128 | $0.47 | $2.4K | 16,734 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2020-01-02 | 2020-01-06 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Dahms Bradford D. | Chief Financial Officer | A Award deriv | 2020-01-02 | 2020-01-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | A Award deriv | 2020-01-02 | 2020-01-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award deriv | 2020-01-02 | 2020-01-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Kogan Elona Esq. | General Counsel | A Award deriv | 2020-01-02 | 2020-01-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Schecter Alison D. | Chief Medical Officer | A Award deriv | 2020-01-02 | 2020-01-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Smolinski Stephen | Chief Commercial Officer | A Award deriv | 2020-01-02 | 2020-01-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Myers Scott Dunseth | Director | A Award deriv | 2019-12-23 | 2019-12-26 | 19,704 | $0.13 | $2.6K | 19,704 | SEC↗ |
| COX CARRIE SMITH | Director | A Award deriv | 2019-12-23 | 2019-12-26 | 32,840 | $0.13 | $4.3K | 32,840 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award deriv | 2019-12-23 | 2019-12-26 | 1,970,443 | $0.13 | $256.2K | 1,970,443 | SEC↗ |
| BARABE TIMOTHY C | Director | A Award deriv | 2019-12-23 | 2019-12-26 | 32,840 | $0.13 | $4.3K | 32,840 | SEC↗ |
| Myers Scott Dunseth | Director | A Award | 2019-12-23 | 2019-12-26 | 39,409 | $1.46 | $57.5K | 80,845 | SEC↗ |
| COX CARRIE SMITH | Director | A Award | 2019-12-23 | 2019-12-26 | 65,681 | $1.46 | $95.9K | 65,681 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award | 2019-12-23 | 2019-12-26 | 3,940,887 | $1.46 | $5.75M | 5,486,463 | SEC↗ |
| BARABE TIMOTHY C | Director | A Award | 2019-12-23 | 2019-12-26 | 65,681 | $1.46 | $95.9K | 83,173 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | J Other | 2019-12-12 | 2019-12-16 | 1,237,028 | — | $0 | 7,293,625 | SEC↗ |
| Brunn Carsten | President and CEO | S Sale | 2019-12-02 | 2019-12-03 | 14,272 | $1.53 | $21.8K | 70,914 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise deriv | 2019-12-01 | 2019-12-03 | 43,750 | — | $0 | 131,250 | SEC↗ |
| Brunn Carsten | President and CEO | M Exercise | 2019-12-01 | 2019-12-03 | 43,750 | — | $0 | 85,186 | SEC↗ |
| COX CARRIE SMITH | Director | A Award deriv | 2019-11-20 | 2019-11-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2019-10-07 | 2019-10-09 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | A Award deriv | 2019-10-07 | 2019-10-09 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award deriv | 2019-10-07 | 2019-10-09 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Smolinski Stephen | Chief Commercial Officer | A Award deriv | 2019-10-07 | 2019-10-09 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Dahms Bradford D. | Chief Financial Officer | A Award deriv | 2019-09-03 | 2019-09-05 | 400,000 | — | $0 | 400,000 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | J Other | 2019-09-03 | 2019-09-05 | 1,237,028 | — | $0 | 0 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | J Other | 2019-09-03 | 2019-09-05 | 1,237,028 | — | $0 | 0 | SEC↗ |
| ZENNER PATRICK J | Director | A Award | 2019-08-20 | 2019-08-20 | 55,248 | $1.81 | $100.0K | 55,248 | SEC↗ |
| Brunn Carsten | President and CEO | A Award | 2019-08-20 | 2019-08-20 | 41,436 | $1.81 | $75.0K | 41,436 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award | 2019-08-20 | 2019-08-20 | 50,000 | $1.81 | $90.5K | 86,114 | SEC↗ |
| Kogan Elona Esq. | General Counsel | A Award | 2019-08-20 | 2019-08-20 | 82,872 | $1.81 | $150.0K | 182,872 | SEC↗ |
| Myers Scott Dunseth | Director | A Award | 2019-08-20 | 2019-08-20 | 41,436 | $1.81 | $75.0K | 41,436 | SEC↗ |
| Smolinski Stephen | Chief Commercial Officer | A Award | 2019-08-20 | 2019-08-20 | 13,812 | $1.81 | $25.0K | 13,812 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award | 2019-08-20 | 2019-08-20 | 1,600,000 | $1.81 | $2.90M | 6,056,597 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award | 2019-08-20 | 2019-08-20 | 1,100,000 | $1.81 | $1.99M | 1,545,576 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | P Buy | 2019-08-14 | 2019-08-16 | 10,000 | $1.74 | $17.4K | 86,418 | SEC↗ |
| BARABE TIMOTHY C | Director | P Buy | 2019-08-13 | 2019-08-15 | 10,000 | $1.72 | $17.2K | 17,492 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | M Exercise deriv | 2019-07-23 | 2019-07-25 | 10,000 | — | $0 | 0 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | M Exercise | 2019-07-23 | 2019-07-25 | 10,000 | $0.47 | $4.7K | 11,606 | SEC↗ |
| Schecter Alison D. | Chief Medical Officer | A Award deriv | 2019-07-15 | 2019-07-17 | 350,000 | — | $0 | 350,000 | SEC↗ |
| BARABE TIMOTHY C | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Farokhzad Omid | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 15,404 | — | $0 | 15,404 | SEC↗ |
| Myers Scott Dunseth | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Nashat Amir | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Sallin Aymeric | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SPRINGER TIMOTHY A | Director, 10% Owner | A Award deriv | 2019-06-14 | 2019-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZENNER PATRICK J | Director | A Award deriv | 2019-06-14 | 2019-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kogan Elona Esq. | General Counsel | A Award deriv | 2019-03-25 | 2019-03-27 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Kogan Elona Esq. | General Counsel | A Award | 2019-03-25 | 2019-03-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2019-02-25 | 2019-02-27 | 330,000 | — | $0 | 330,000 | SEC↗ |
| Nashat Amir | Director | P Buy | 2019-01-25 | 2019-01-29 | 11,258 | $1.50 | $16.9K | 26,760 | SEC↗ |
| Nashat Amir | Director | P Buy | 2019-01-25 | 2019-01-29 | 1,125,756 | $1.50 | $1.69M | 2,676,234 | SEC↗ |
| Nashat Amir | Director | P Buy | 2019-01-25 | 2019-01-29 | 7,711 | $1.50 | $11.6K | 18,329 | SEC↗ |
| Nashat Amir | Director | P Buy | 2019-01-25 | 2019-01-29 | 21,941 | $1.50 | $32.9K | 52,156 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2019-01-25 | 2019-03-29 | 66,666 | $1.50 | $100.0K | 76,418 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2019-01-25 | 2019-03-29 | 4,000,000 | $1.50 | $6.00M | 4,456,597 | SEC↗ |
| Farokhzad Omid | Director | P Buy | 2019-01-25 | 2019-03-29 | 83,333 | $1.50 | $125.0K | 83,333 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award deriv | 2019-01-07 | 2019-01-08 | 100,000 | $2.60 | $260.0K | 100,000 | SEC↗ |
| Smolinski Stephen | Chief Commercial Officer | A Award deriv | 2019-01-07 | 2019-01-08 | 100,000 | $2.60 | $260.0K | 100,000 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | A Award deriv | 2019-01-07 | 2019-01-08 | 100,000 | $2.60 | $260.0K | 100,000 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | M Exercise deriv | 2019-01-07 | 2019-02-21 | 36,114 | $2.77 | $100.0K | 43,629 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | M Exercise | 2019-01-07 | 2019-02-21 | 36,114 | $2.77 | $100.0K | 36,114 | SEC↗ |
| Farokhzad Omid | Director | A Award deriv | 2018-12-02 | 2018-12-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2018-12-01 | 2018-12-03 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Brunn Carsten | President and CEO | A Award deriv | 2018-12-01 | 2018-12-03 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ZENNER PATRICK J | Director | A Award deriv | 2018-06-15 | 2018-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SPRINGER TIMOTHY A | Director | A Award deriv | 2018-06-15 | 2018-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Sallin Aymeric | Director | A Award deriv | 2018-06-15 | 2018-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Nashat Amir | Director | A Award deriv | 2018-06-15 | 2018-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HUTT PETER BARTON | Director | A Award deriv | 2018-06-15 | 2018-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BARABE TIMOTHY C | Director | A Award deriv | 2018-06-15 | 2018-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Farokhzad Omid | Director | A Award deriv | 2018-06-15 | 2018-06-19 | 15,404 | — | $0 | 15,404 | SEC↗ |
| Leaman John Harold | CFO, Treas. & Hd Corp Strate | A Award deriv | 2018-06-15 | 2018-06-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Smolinski Stephen | Chief Commercial Officer | A Award deriv | 2018-06-15 | 2018-06-19 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Abraham David | GC, CCO & Corporate Secretar | A Award deriv | 2018-06-15 | 2018-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kishimoto Takashi Kei | Chief Scientific Officer | A Award deriv | 2018-06-15 | 2018-06-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Johnston Lloyd P. | COO and SVP, R&D | A Award deriv | 2018-06-15 | 2018-06-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Farokhzad Omid | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Smolinski Stephen | Chief Commercial Officer | A Award deriv | 2017-11-17 | 2017-11-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Leaman John Harold | CFO, Treas. & Hd Corp Strate | A Award deriv | 2017-11-17 | 2017-11-20 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Sands Earl | Chief Medical Officer | P Buy | 2017-11-17 | 2017-11-21 | 7,500 | $10.26 | $77.0K | 7,500 | SEC↗ |
| Abraham David | GC, CCO & Corporate Secretar | P Buy | 2017-11-14 | 2017-11-14 | 5,405 | $9.25 | $50.0K | 5,405 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2017-11-14 | 2017-11-16 | 57,598 | $9.27 | $533.9K | 461,349 | SEC↗ |
| CAUTREELS WERNER | President and CEO | P Buy | 2017-11-13 | 2017-11-14 | 20,000 | $9.31 | $186.2K | 321,203 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2017-11-10 | 2019-03-29 | 4,752 | $9.03 | $42.9K | 9,752 | SEC↗ |
| BARABE TIMOTHY C | Director | P Buy | 2017-11-10 | 2017-11-13 | 2,500 | $9.00 | $22.5K | 7,492 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2017-11-10 | 2017-11-13 | 21,586 | $9.04 | $195.1K | 398,999 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2017-11-10 | 2017-11-13 | 4,752 | $9.03 | $42.9K | 403,751 | SEC↗ |
| BARABE TIMOTHY C | Director | P Buy | 2017-11-09 | 2017-11-13 | 2,500 | $9.73 | $24.3K | 4,992 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2017-11-09 | 2017-11-13 | 4,900 | $9.33 | $45.7K | 4,900 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2017-11-09 | 2017-11-13 | 100 | $9.78 | $978 | 5,000 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2017-11-09 | 2017-11-13 | 900 | $9.74 | $8.8K | 377,413 | SEC↗ |
| SPRINGER TIMOTHY A | Director | P Buy | 2017-11-09 | 2017-11-13 | 21,100 | $9.33 | $196.9K | 376,513 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-26 | 2017-09-28 | 464 | $18.91 | $8.8K | 10,618 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-26 | 2017-09-28 | 677 | $18.91 | $12.8K | 15,502 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-26 | 2017-09-28 | 67,764 | $18.91 | $1.28M | 1,550,478 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-26 | 2017-09-28 | 1,321 | $18.91 | $25.0K | 30,215 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-25 | 2017-09-26 | 245 | $18.99 | $4.7K | 11,082 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-25 | 2017-09-26 | 35,872 | $18.99 | $681.2K | 1,618,242 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-25 | 2017-09-26 | 359 | $18.99 | $6.8K | 16,179 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-25 | 2017-09-26 | 699 | $18.99 | $13.3K | 31,536 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-22 | 2017-09-26 | 790 | $19.26 | $15.2K | 32,235 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-22 | 2017-09-26 | 278 | $19.26 | $5.4K | 11,327 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-22 | 2017-09-26 | 40,562 | $19.26 | $781.2K | 1,654,114 | SEC↗ |
| Nashat Amir | Director | S Sale | 2017-09-22 | 2017-09-26 | 406 | $19.26 | $7.8K | 16,538 | SEC↗ |